HIGHLIGHTS
- who: Diagnosed Acute Myeloid Leukaemia et al. from the Department of Hematology, the Affiliated DrumTower Hospital of Nanjing University Medical School, Nanjing, Jiangsu, PR China have published the research work: Meta-Analysis of Randomised Clinical Trials Comparing Idarubicin + Cytarabine with Daunorubicin Cytarabine as the Induction Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukaemia, in the Journal: PLOS ONE | www.plosone.org
- what: The aim of treatment is to achieve complete remission (CR), and further treatment is performed to prevent relapse.
- how: A subgroup analysis was conducted in an effort to determine whether . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.